UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030399
Receipt No. R000034710
Scientific Title Phase II study of afatinib for non-small cell lung cancer acquired resistance to osimertinib (North Japan Lung Cancer Study Group 1801)
Date of disclosure of the study information 2017/12/15
Last modified on 2019/06/16 13:30:30

No. Disposal Last modified on Item of update
1 Insert 2017/12/14 19:52:05
2 Update 2017/12/16 06:45:10 Anticipated trial start date
3 Update 2017/12/16 06:47:44 Anticipated trial start date
4 Update 2017/12/16 07:00:06 Anticipated trial start date
5 Update 2017/12/17 08:10:27 Organization
Category of Funding Organization
6 Update 2017/12/27 16:36:38 Organization
7 Update 2018/12/15 09:13:33 Recruitment status
8 Update 2019/06/16 13:30:30 Date of IRB
Last follow-up date


Contact us.